Invitae Co. (NYSE:NVTA – Get Rating) CFO Yafei Wen sold 17,042 shares of the stock in a transaction dated Tuesday, May 17th. The stock was sold at an average price of $3.81, for a total value of $64,930.02. Following the completion of the sale, the chief financial officer now owns 344,374 shares of the company’s […]
Invitae Co. (NYSE:NVTA – Get Rating) CEO Sean E. George sold 18,296 shares of the company’s stock in a transaction that occurred on Tuesday, May 17th. The shares were sold at an average price of $3.81, for a total value of $69,707.76. Following the sale, the chief executive officer now directly owns 794,691 shares in […]
Invitae (NYSE:NVTA – Get Rating) announced its quarterly earnings data on Tuesday. The medical research company reported ($0.78) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.76) by ($0.02), MarketWatch Earnings reports. The company had revenue of $123.70 million during the quarter, compared to analysts’ expectations of $129.31 million. Invitae had a […]
Wall Street analysts expect Invitae Co. (NYSE:NVTA – Get Rating) to report sales of $126.72 million for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for Invitae’s earnings. The highest sales estimate is $127.95 million and the lowest is $125.30 million. Invitae reported sales of $103.62 million in the same quarter […]
Invitae (NYSE:NVTA – Get Rating) and American Shared Hospital Services (NYSE:AMS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, dividends, valuation, earnings, profitability and analyst recommendations. Insider and Institutional Ownership 90.6% of Invitae shares […]